Jingyao Wang

Title: Innovations of Jingyao Wang in Peptide Synthesis

Introduction

Jingyao Wang is an accomplished inventor based in Carmel, IN (US). She has made significant contributions to the field of peptide synthesis, particularly through her innovative patent that enhances the efficiency of manufacturing peptides.

Latest Patents

Jingyao Wang holds a patent for a device and method known as the "Three resin reactors in series peptide synthesizer." This Solid Phase Peptide Synthesis (SPPS) device comprises at least two reactors, each containing a quantity of SPPS resin. The reactors are arranged in series, allowing for a streamlined process in peptide manufacturing. A de-protecting agent is introduced to the first reactor and subsequently transferred to the second and third reactors, effectively de-protecting the protected N-group. The system also incorporates wash solvents and amino acid activated ester solutions, which are added in series to facilitate the coupling of amino acids to the de-protected N-group. This innovative approach reduces the overall solvent required and utilizes online LCMS to monitor the progress and identity of reactions occurring within the solid phase resin particles.

Career Highlights

Jingyao Wang is currently employed at Eli Lilly and Company, where she continues to advance her research and development efforts in peptide synthesis. Her work has garnered attention for its potential applications in pharmaceuticals and biotechnology.

Collaborations

Jingyao has collaborated with notable colleagues, including Martin D Johnson and Michael E Kopach, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jingyao Wang's contributions to peptide synthesis through her innovative patent demonstrate her expertise and commitment to advancing the field. Her work at Eli Lilly and Company continues to pave the way for new developments in peptide manufacturing.